ClinicalTrials.gg
Status unknownNCT02572804Updated Nov 2, 2016

Comparing Rectus Sheath Catheter to Epidural Post Cystectomy

An interventional study of Epidural and Rectus Sheath Catheters in Bladder Cancer and Postoperative Pain, sponsored by Vancouver Coastal Health. Status unknown at 1 site in Canada. Open to participants aged 19 Years and older. Per ClinicalTrials.gov, last updated 2016-11-02.

Sponsored by Vancouver Coastal Health · Not applicable, Interventional, and Treatment

How we know

The sponsor has not verified this record recently (last verified Oct 2016), so the status shown — last known as Recruiting — may be out of date.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
160
Allocation
Randomized
Ages
19 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 153 studies in Urinary Bladder Neoplasms with a site in Canada — 32 open to participants now, 59 under way, 21 of them phase 3. Urinary Bladder Neoplasms · Canada.

Planned enrollment
64th of 135
160 · median 154
Started
2015
with 8 others
No phase
13 of 153
3 open now
Registered
55th of 153
by date

Among the 153 studies in Urinary Bladder Neoplasms with a site in Canada, this one is the 64th largest by planned enrollment of the 135 interventional ones that give a count, is one of 9 that started in 2015, is one of 13 with no phase, and was the 55th registered.

Urinary Bladder Neoplasms

1,803 studies on the registry are indexed under Urinary Bladder Neoplasms; 446 are open to participants now.

Browse Urinary Bladder Neoplasms studies →

Open to participants now

32 of the 153 studies in Urinary Bladder Neoplasms with a site in Canada are open now. Recruiting first, the newest first:

27 more — sign in →

All 32 open studies →

A study can be open while its sites in Canada have not opened yet or have stopped. Only those recruiting at a site in Canada →

Who these studies take

Of the 336 Urinary Bladder Neoplasms studies recruiting now, 256 (76%) set no upper age limit and 22 (7%) stop at 75 or younger; 22 take children under 18; 21 take healthy volunteers.

This study: 19 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 153 studies in Urinary Bladder Neoplasms with a site in Canada, or all of them as a file.
02

Study summary

This is a prospective randomised controlled trial that will compare the outcomes of rectus sheath catheters to epidurals in patients who have undergone a cystectomy, via a lower midline abdominal incision for bladder cancer.

Read the detailed description

This study will compare the outcomes of two different pain control techniques, used as standard of care, following major abdominal surgery for bladder removal. Rectus sheath catheters are small tubes that are positioned into a specific area of the cut abdominal wall at the end of surgery; whereas an epidural is a tube that is positioned into the back. Both allow administration of local anaesthetic for pain control. The current gold standard is an epidural. This study will aim to evaluate this and show the comparative efficacy of the rectus sheath catheter, which anecdotally the investigators have found superior in practice.

03

Conditions studied

  • Bladder Cancer
  • Postoperative Pain

Keywords

  • bladder cancer-cystectomy
  • rectus sheath catheter
  • epidural
04

Who can participate

Ages eligible
19 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients over or equal to the age of 19 years old who can understand the study protocol and are able to give consent
  • Patients with an American Society of Anaesthesiology (ASA) classification 1 to 3
  • Patients must have a preoperative oral 24 hour opioid consumption of less than or equal to 30mg morphine equivalents
  • Patients must be able to understand and be able to use patient controlled analgesia
  • Patients must be undergoing a cystectomy with an infra-umbilical midline incision

Exclusion criteria

Exclusion Criteria:

  • Patients with greater than 40
  • Patients with an allergy to local anaesthetics
  • Patients who are to having an epidural (e.g. coagulopathic, distorted anatomy, patient refusal, infection at the site of proposed insertion)
  • Patients with previous spinal surgery at the proposed site of epidural
  • Patients with neurodegenerative disorders or spinal cord injury
  • Patients with known anatomy that would not permit placement of the rectus sheath catheters e.g. Prune Belly Syndrome
  • Patients undergoing another complex abdominal procedure in addition to cystectomy and reconstruction requiring extension of the abdominal incision above the umbilicus.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
160 participants (estimated)

Study arms

  • Active comparator
    Rectus Sheath Catheter Group

    Patients will have rectus sheath catheters surgically inserted with infusion of 0.125% Bupivicaine at 5mls an hour.

    Device: Rectus Sheath Catheters

  • Active comparator
    Epidural Group

    Patients will have a standard epidural placement with infusion of 0.125% Bupivicaine at an initial rate of 5mls/hour, titrated to response

    Device: Epidural

Interventions

  • DeviceEpidural

    Patients in this group will have an epidural inserted in a standard fashion, prior to the induction of anesthesia. These will be infused with 0.125% Bupivicaine at an initial rate of 5mls/hour, titrated to response. Patients will also receive a patient controlled analgesia with hydromorphone 0.2mg/ml, bolus of 200 micrograms with 6 minute lock out (variable in accordance with anesthetic preference).

  • DeviceRectus Sheath Catheters

    Patients in this group will have surgically inserted rectus sheath catheters (bilaterally), immediately prior to closure of the anterior abdominal wall. These will be infused with 0.125% Bupivicaine at 5mls an hour at a standard rate.Patients will also receive a patient controlled analgesia with hydromorphone 0.2mg/ml, bolus of 200 micrograms with 6 minute lock out (variable in accordance with anesthetic preference).

06

What researchers measure

Primary outcomes

  1. Cumulative post-operative opioid consumption

    Time frame: To Day 3 post-op

Secondary outcomes

  1. Visual Analogue Score pain score

    Time frame: within 4 hours post-operatively and on days 1, 2 and 3 post-operatively

  2. Patient total intraoperative Opioid requirement

    Opioid requirement will be measured in morphine equivalents and reported as such on a per patient basis and measured throughout the operation.

    Time frame: Intraoperatively

  3. Total patient fluid requirements throughout hospital admission

    Measurement of individual patient fluid balance will be performed up to and including day 3 post-operatively.

    Time frame: From the start of the operation to day 3 post-operatively.

  4. Recorded evidence of hypotension

    Hypotension for the purposes of this study is defined as a systolic blood pressure of less than 95.

    Time frame: Until Day 3 postoperatively

  5. Duration of post-operative ileus

    Ileus will be measured by a 3 separate variables - bowel sounds, passing of flatus and opening of bowels. The post-operative day on which each of these targets is achieved for each patient will be recorded.

    Time frame: This will be measured during the patients' inpatient hospital stay - usually up to a maximum of 10 days.

  6. Time to mobilisation

    Time frame: The day at which patient achieves mobilisation - usually at a maximum of 5 days post-operatively

  7. Length of Hospital Stay

    Time frame: The day at which patient is discharged from hospital- usually on average 10 days post-operatively

  8. Patient Satisfaction with pain control

    Patient satisfaction with pain control will be measured using a 9-point Likert scale on day 3 post-operatively.

    Time frame: Day 3 post operatively

  9. Complications and side effects.

    At 30 days an electronic note review will be performed to evaluate for 30 day mortality and morbidity.

    Time frame: 30 day morbidity and mortality

07

Study locations

1 of 1 sites recruiting
  • Vancouver Prostate Centre, Dept. Urologic Sciences
    Vancouver, British Columbia V6K 2H4, Canada
    Recruiting
    • Edmund CP Chedgy, MBBS, FRCS · Contactechedgy@prostatecentre.com · 604-875-4111
    • Genevieve Lowe, MBBS · Contact604-875-4304
08

References and documents

Publications

  • Bochner BH, Dalbagni G, Sjoberg DD, Silberstein J, Keren Paz GE, Donat SM, Coleman JA, Mathew S, Vickers A, Schnorr GC, Feuerstein MA, Rapkin B, Parra RO, Herr HW, Laudone VP. Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: A Randomized Clinical Trial. Eur Urol. 2015 Jun;67(6):1042-1050. doi: 10.1016/j.eururo.2014.11.043. Epub 2014 Dec 8. PubMed 25496767 ↗
  • Block BM, Liu SS, Rowlingson AJ, Cowan AR, Cowan JA Jr, Wu CL. Efficacy of postoperative epidural analgesia: a meta-analysis. JAMA. 2003 Nov 12;290(18):2455-63. doi: 10.1001/jama.290.18.2455. PubMed 14612482 ↗
  • Rigg JR, Jamrozik K, Myles PS, Silbert BS, Peyton PJ, Parsons RW, Collins KS; MASTER Anaethesia Trial Study Group. Epidural anaesthesia and analgesia and outcome of major surgery: a randomised trial. Lancet. 2002 Apr 13;359(9314):1276-82. doi: 10.1016/S0140-6736(02)08266-1. PubMed 11965272 ↗
  • Ready LB. Acute pain: lessons learned from 25,000 patients. Reg Anesth Pain Med. 1999 Nov-Dec;24(6):499-505. doi: 10.1016/s1098-7339(99)90038-x. No abstract available. PubMed 10588551 ↗
  • Gustafsson UO, Hausel J, Thorell A, Ljungqvist O, Soop M, Nygren J; Enhanced Recovery After Surgery Study Group. Adherence to the enhanced recovery after surgery protocol and outcomes after colorectal cancer surgery. Arch Surg. 2011 May;146(5):571-7. doi: 10.1001/archsurg.2010.309. Epub 2011 Jan 17. PubMed 21242424 ↗
  • Guillotreau J, Game X, Mouzin M, Doumerc N, Mallet R, Sallusto F, Malavaud B, Rischmann P. Radical cystectomy for bladder cancer: morbidity of laparoscopic versus open surgery. J Urol. 2009 Feb;181(2):554-9; discussion 559. doi: 10.1016/j.juro.2008.10.011. Epub 2008 Dec 13. PubMed 19084856 ↗
  • Dutton TJ, McGrath JS, Daugherty MO. Use of rectus sheath catheters for pain relief in patients undergoing major pelvic urological surgery. BJU Int. 2014 Feb;113(2):246-53. doi: 10.1111/bju.12316. Epub 2013 Aug 13. PubMed 23937574 ↗
09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Sep 2015, a primary completion of Dec 2016 and a completion of Jun 2017. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 6, 2015
First posted
Oct 9, 2015
Start
Sep 2015
Primary completionEst.
Dec 2016
CompletionEst.
Jun 2017
Last update
Nov 2, 2016
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 2, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02572804
Lead sponsor
Vancouver Coastal Health
Collaborators
University of British Columbia, Vancouver Prostate Centre
Responsible party
Dr. Alan I. So (Urologic Surgeon, Vancouver Coastal Health) — Principal investigator
First posted
Oct 9, 2015
Start date
Sep 2015
Primary completion
Dec 2016 (estimated)
Completion
Jun 2017 (estimated)
Last update
Nov 2, 2016

Study contacts

Edmund CP Chedgy, MBBS,FRCS
Contact
echedgy@prostatecentre.com
+1 604-875-4111 ext. 69629
Geneveive Lowe, MBBS
Contact
604-875-4304
Martin E Gleave, MD
principal investigator · University of British Columbia

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Oct 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion